108 related articles for article (PubMed ID: 20594264)
1. Education and imaging. Gastrointestinal: Transmural colonic metastasis arising from primary cholangiocarcinoma.
Fujii K; Goto A; Yoshida Y; Suzuki K; Matunaga Y; Shinomura Y
J Gastroenterol Hepatol; 2010 Jul; 25(7):1329. PubMed ID: 20594264
[No Abstract] [Full Text] [Related]
2. Case report: appearance of an intestinal metastasis from intrahepatic cholangiocarcinoma occurring 5 years after resection of the primary tumor.
Izzo F; Piccirillo M; Albino V; Botti G; Foggia M; Iodice R; Pagano F; Piccirillo G; Tornillo L; Delrio P
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):892-4. PubMed ID: 19550345
[TBL] [Abstract][Full Text] [Related]
3. Metastatic colon cancer from intrahepatic cholangiocarcinoma.
Wakahara T; Tsukamoto T; Kitamura S; Watanabe A; Tsujimura T; Nakamura Y; Toyokawa A; Onishi N; Hamabe Y; Mukai H; Teramura K
J Hepatobiliary Pancreat Surg; 2005; 12(5):415-8. PubMed ID: 16258812
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatous cholangiocarcinoma.
Gupta K; Powari M; Dey P
Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
[No Abstract] [Full Text] [Related]
5. Cholangiocarcinoma presenting as metastases to the cervical spine.
Kidambi T; Mahajan A; DiBardino D
Am J Med; 2011 May; 124(5):e1-2. PubMed ID: 21531219
[No Abstract] [Full Text] [Related]
6. Metastatic cholangiocarcinoma presenting as ovarian cancer: a rare Krukenberg tumor.
Sharma P; Jaffe PE; Bhattacharyya A
Am J Gastroenterol; 1997 Mar; 92(3):531-3. PubMed ID: 9068492
[No Abstract] [Full Text] [Related]
7. Adrenal metastasis from intrahepatic cholangiocarcinoma.
Pandey D; Lee KH; Wong SY; Tan KC
Liver Int; 2007 Sep; 27(7):1016. PubMed ID: 17696942
[No Abstract] [Full Text] [Related]
8. Intestinal obstruction caused by colonic metastasis from intrahepatic cholangiocarcinoma 6 years after removal of the primary tumor: report of a case.
Tokodai K; Kawagishi N; Miyagi S; Takeda I; Sato K; Akamatsu Y; Sekiguchi S; Ishida K; Satomi S
Surg Today; 2012 Aug; 42(8):797-800. PubMed ID: 22307905
[TBL] [Abstract][Full Text] [Related]
9. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
[TBL] [Abstract][Full Text] [Related]
10. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
12. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
13. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
[TBL] [Abstract][Full Text] [Related]
14. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
[TBL] [Abstract][Full Text] [Related]
15. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
16. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
Baskin-Bey ES; Moreno Luna LE; Gores GJ
J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
[No Abstract] [Full Text] [Related]
18. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
20. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
